261 related articles for article (PubMed ID: 25758816)
1. Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction.
You IC; Bian F; Volpe EA; de Paiva CS; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2224-33. PubMed ID: 25758816
[TBL] [Abstract][Full Text] [Related]
2. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
3. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
[TBL] [Abstract][Full Text] [Related]
4. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Chloroquine on the Development of Dry Eye in Sjögren Syndrome Animal Model.
Lee HJ; Shin S; Yoon SG; Cheon EJ; Chung SH
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3708-3716. PubMed ID: 31479110
[TBL] [Abstract][Full Text] [Related]
6. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland.
Pitcher JD; De Paiva CS; Pelegrino FS; McClellan AJ; Raince JK; Pangelinan SB; Rahimy E; Farley WJ; Stern ME; Li DQ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3221-7. PubMed ID: 21273534
[TBL] [Abstract][Full Text] [Related]
8. MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjögren syndrome patients.
Yu DF; Chen Y; Han JM; Zhang H; Chen XP; Zou WJ; Liang LY; Xu CC; Liu ZG
Exp Eye Res; 2008 Feb; 86(2):403-11. PubMed ID: 18184611
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
11. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.
De Paiva CS; Hwang CS; Pitcher JD; Pangelinan SB; Rahimy E; Chen W; Yoon KC; Farley WJ; Niederkorn JY; Stern ME; Li DQ; Pflugfelder SC
Rheumatology (Oxford); 2010 Feb; 49(2):246-58. PubMed ID: 20007286
[TBL] [Abstract][Full Text] [Related]
12. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
Xiao W; Xu GT; Zhang J; Zhang J; Zhang Y; Ye W
Exp Eye Res; 2015 Sep; 138():145-52. PubMed ID: 26187517
[TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
15. Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice.
Pelegrino FS; Volpe EA; Gandhi NB; Li DQ; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2012 Nov; 14(6):R234. PubMed ID: 23116218
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome.
Contreras-Ruiz L; Regenfuss B; Mir FA; Kearns J; Masli S
PLoS One; 2013; 8(9):e75937. PubMed ID: 24086667
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
Nguyen CQ; Sharma A; She JX; McIndoe RA; Peck AB
Exp Eye Res; 2009 Mar; 88(3):398-409. PubMed ID: 19103199
[TBL] [Abstract][Full Text] [Related]
18. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye.
Li Z; Woo JM; Chung SW; Kwon MY; Choi JS; Oh HJ; Yoon KC
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):155-62. PubMed ID: 23211823
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Mesenchymal Stem Cells on Dry Eye in Sjogren Syndrome Mouse Model.
Shin S; Yoon SG; Kim M; Cheon EJ; Jeon Y; Lee HJ; Chung SH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]